News

Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...
Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.
A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...
A study by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies hold ...
Review quarterly and annual revenue, net income, and cash flow for Axon Enterprise Inc (AXON:XNAS) stock through the last fiscal year.
See the latest Axon Enterprise Inc stock price (AXON:XMEX), related news, valuation, dividends and more to help you make your investing decisions.
Research indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.
Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.